Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic, GeneGo, Simulations Plus, Pharsight


Gene Logic Genomics Revenue 'Significantly Lower' Than Expected for Q2 and 2005

Gene Logic said this week that revenue for its genomics division will be "significantly lower" than anticipated for both the second quarter and the full year of 2006, and it is withdrawing its financial guidance for 2006 and 2007 as a result.

The company has not provided specific guidance for either fiscal year, but said in February that it expected to reach profitability in 2007 [BioInform 02-24-06].

The company said it is performing a review of the genomics division's strategy, and it expects to announce those results within 90 days. The performance of Gene Logic's drug-repositioning division and its preclinical division will not deviate significantly from estimates, the company said.

Dennis Rossi, Gene Logic's senior vice president and general manager of genomics, has resigned for "personal reasons and to pursue other career opportunities," the company said.

Boehringer Ingelheim to Use MetaCore Software for Toxicogenomics

GeneGo said this week that Boehringer Ingelheim has licensed its MetaCore data-mining software, which it will primarily use in toxicogenomics research.

Julie Bryant, vice president of business development at GeneGo, said that toxicogenomics "is one of the main applications" of the platform, which includes "tools and workflows specifically for the analysis of toxicogenomics datasets."

Financial terms of the agreement were not provide.

Simulations Plus Sees 26 Percent Increase in Preliminary Q3 Revenues

Simulations Plus reported preliminary financial results for the third fiscal quarter of its 2006 fiscal year ended May 31 this week.

Revenues for the quarter increased 26 percent to $1.8 million from $1.4 million in the third quarter of fiscal year 2005.

The company said in a statement that this is a new record for third-quarter revenues.

Revenues from pharmaceutical software and services were $1.1 million, an increase of 66 percent from $662,000 in the third quarter of fiscal year 2005.

CTC Lab Systems to Distribute Pharsight Software in Japan

Japan's CTC Laboratory Systems will distribute Pharsight's software systems in the Japanese market, Pharsight said this week.

CTC will distribute Pharsight Knowledgebase Server, PKS Reporter, PKS Validation Suite, and Pharsight Trial Simulator.

Filed under

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.